When CXCR2 is inhibited, native OBSC TME seems to mediate tumor-permissive effects, and even tumor-promoting effects are produced in combination with dexamethasone treatment—this phenomenon is contrary or missing when PLX5622-pretreatment of the OBSC was performed. This evidence concerns the gene CXCR2 and neoplasm.